CD247, a Potential T Cell-Derived Disease Severity and Prognostic Biomarker in Patients With Idiopathic Pulmonary Fibrosis

• Published in: Frontiers in immunology Vol. 12; p. 762594
• Main Authors: Li, Yupeng, Chen, Shibin, Li, Xincheng, Wang, Xue, Li, Huiwen, Ning, Shangwei, Chen, Hong
• Format: Journal Article
• Language: English
• Published: Switzerland Frontiers Media S.A 22-11-2021
• Subjects: Aged; biomarker; CD247; CD3 Complex - blood; CD3 Complex - genetics; CD3 Complex - immunology; Down-Regulation; Female; Gene Expression; Humans; idiopathic pulmonary fibrosis; Idiopathic Pulmonary Fibrosis - blood; Idiopathic Pulmonary Fibrosis - genetics; Idiopathic Pulmonary Fibrosis - immunology; immune response; Immunology; inflammation response; Lung - immunology; Male; Middle Aged; Myosin Light Chains - blood; Myosin Light Chains - genetics; Prognosis; Protein Interaction Maps; Severity of Illness Index; T-Lymphocytes - immunology; CD247; idiopathic pulmonary fibrosis; biomarker; immune response; prognosis; inflammation response
• ISSN: 1664-3224; 1664-3224
• DOI: 10.3389/fimmu.2021.762594

Idiopathic pulmonary fibrosis (IPF) has high mortality worldwide. The CD247 molecule (CD247, as known as T-cell surface glycoprotein CD3 zeta chain) has been reported as a susceptibility locus in systemic sclerosis, but its correlation with IPF remains unclear.
Datasets were acquired by researching the Gene Expression Omnibus (GEO). CD247 was identified as the hub gene associated with percent predicted diffusion capacity of the lung for carbon monoxide (Dlco% predicted) and prognosis according to Pearson correlation, logistic regression, and survival analysis.
CD247 is significantly downregulated in patients with IPF compared with controls in both blood and lung tissue samples. Moreover, CD247 is significantly positively associated with Dlco% predicted in blood and lung tissue samples. Patients with low-expression CD247 had shorter transplant-free survival (TFS) time and more composite end-point events (CEP, death, or decline in FVC >10% over a 6-month period) compared with patients with high-expression CD247 (blood). Moreover, in the follow-up 1st, 3rd, 6th, and 12th months, low expression of CD247 was still the risk factor of CEP in the GSE93606 dataset (blood). Thirteen genes were found to interact with CD247 according to the protein-protein interaction network, and the 14 genes including CD247 were associated with the functions of T cells and natural killer (NK) cells such as PD-L1 expression and PD-1 checkpoint pathway and NK cell-mediated cytotoxicity. Furthermore, we also found that a low expression of CD247 might be associated with a lower activity of TIL (tumor-infiltrating lymphocytes), checkpoint, and cytolytic activity and a higher activity of macrophages and neutrophils.
These results imply that CD247 may be a potential T cell-derived disease severity and prognostic biomarker for IPF.